1.0
15 Sept 2025
Anonymous employee
Former employee
Recommend
CEO approval
Business outlook
Pros
People outside of management seem decent.
Cons
Let's let facts speak for themselves- Bio-techne bought a company for $275Million in 2018. Somehow they managed to drive that company into the ground- selling it for a whopping $15Million due to close this month! Buy high, sell low. I'd be pissed if I was an investor... Stay far away- this company's leaderhship has absolutely no idea how to run a business. Toxic place, so grateful to be out of that shit-show.